Q3 2024 EPS Estimates for AngioDynamics, Inc. Reduced by Zacks Research (NASDAQ:ANGO)
AngioDynamics, Inc. (NASDAQ:ANGO – Free Report) – Zacks Research lowered their Q3 2024 earnings per share (EPS) estimates for AngioDynamics in a research report issued on Wednesday, March 13th. Zacks Research analyst D. Dey now expects that the medical instruments supplier will earn ($0.15) per share for the quarter, down from their previous forecast of […]
More Stories
Sysco Co. (NYSE:SYY) Shares Purchased by Leelyn Smith LLC
Leelyn Smith LLC boosted its stake in Sysco Co. (NYSE:SYY – Free Report) by 5.0% in the 3rd quarter, according...
Stonebrook Private Inc. Lowers Position in Johnson & Johnson (NYSE:JNJ)
Stonebrook Private Inc. trimmed its stake in Johnson & Johnson (NYSE:JNJ – Free Report) by 0.5% during the 3rd quarter,...
49 Wealth Management LLC Grows Stock Position in Pfizer Inc. (NYSE:PFE)
49 Wealth Management LLC increased its position in Pfizer Inc. (NYSE:PFE – Free Report) by 7.4% in the 3rd quarter,...
Pitcairn Co. Has $2.91 Million Stock Holdings in NextEra Energy, Inc. (NYSE:NEE)
Pitcairn Co. cut its position in shares of NextEra Energy, Inc. (NYSE:NEE – Free Report) by 3.2% during the third...
Meridian Wealth Management LLC Makes New $1.65 Million Investment in The Walt Disney Company (NYSE:DIS)
Meridian Wealth Management LLC acquired a new position in shares of The Walt Disney Company (NYSE:DIS – Free Report) during...
NextEra Energy, Inc. (NYSE:NEE) Shares Sold by Hamilton Point Investment Advisors LLC
Hamilton Point Investment Advisors LLC trimmed its holdings in NextEra Energy, Inc. (NYSE:NEE – Free Report) by 0.6% in the...